Purple Biotech (PPBT) has released an update.
Maximize Your Portfolio with Data Driven Insights:
- Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed investment decisions.
- Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with Your Smart Portfolio
Purple Biotech has announced a $2.8 million registered direct offering of American Depositary Shares, with H.C. Wainwright & Co. serving as the exclusive placement agent. The funds will support the company’s oncology therapeutic candidates and general corporate needs. The offering is expected to close around December 4, 2024, pending customary conditions.
For further insights into PPBT stock, check out TipRanks’ Stock Analysis page.
